C0022688||natural killer cells
C0243095||antitumor activity
C0242614||epigenetic imprinting
C0039215||CD4(+) T cell
C0022688||Natural killer (NK) cell
C0574032||infusions
C0006826||cancer
C0022688||NK cell
C1326120||activation
C0574032||infusion
C0022688||NK cells
C0079189||cytokines
C0123759||IL-12
C0254610||15
C0383327||18
C0022688||NK cell
C0243095||antitumor activity
C0022688||NK cells
C3850137||in vitro
C0123759||IL-12
C0254610||15
C0383327||18
C0254610||IL-15
C0243095||antitumor activity
C0024312||lymphopenic
C1419248||RAG-2(-/-)
C0026809||mice
C0022688||NK cell
C0021745||IFNγ
C0021920||non-coding sequence
C0021920||conserved non-coding sequence
C1334085||Ifng
C1708726||locus
C0040649||transcription
C1334085||Ifng
C0012644||xenograft melanoma mouse model
C0086418||human
C0123759||IL-12
C0254610||15
C0383327||18
C0022688||NK cells
C0027651||tumors
C1419248||RAG-2(-/-)
C0026809||mice
C0039215||CD4(+) T cells
C0022688||NK cells
C0021745||IFNγ
C0021756||IL-2
C0039215||CD4(+) T cell
C1326120||activation
C1326161||homeostatic proliferation
C0024432||macrophages
C0022688||NK cell
C0243095||antitumor activity
C0022688||NK cells
C0079189||cytokines
C0242614||epigenetic imprinting
C0021745||IFNγ
C0079189||cytokine
C0022688||NK cells
C0039215||CD4(+) T cell
C1326120||activation
C0024312||lymphopenic
C0022688||NK cell
C0278348||cancer immunotherapy